BDBM323039 5-Methyl-4-[({(1R,2R)-2-[4-(3-methyl-1H- pyrazol-5-yl)benzoyl]- cyclohexyl}carbonyl)amino]-1H-pyrazole- 3-carboxamide::US10183947, Example 22::US10508119, Example 22::US11001589, Example 22

SMILES Cc1cc([nH]n1)-c1ccc(cc1)C(=O)[C@@H]1CCCC[C@H]1C(=O)Nc1c(C)[nH]nc1C(N)=O

InChI Key

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 323039   

TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM323039(5-Methyl-4-[({(1R,2R)-2-[4-(3-methyl-1H- pyrazol-5...)
Affinity DataIC50:  24nMAssay Description:Compounds were tested in a competition binding assay using 3H-MK591 as tracer. (Preparation of MK-591 is described in Bioorg. Med. Chem. Lett. 1999, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent